Otsuka Holdings
4578.T
#775
Rank
โ‚น2.880 T
Marketcap
โ‚น5,454
Share price
-0.12%
Change (1 day)
23.49%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: โ‚น96.15 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are โ‚น14.47 Billion. In 2023 the company made an earning of โ‚น96.15 Billion a decrease over its 2022 earnings that were of โ‚น121.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023โ‚น96.15 B-20.93%
2022โ‚น121.60 B-12.7%
2021โ‚น139.29 B-19.92%
2020โ‚น173.94 B13.9%
2019โ‚น152.72 B52.07%
2018โ‚น100.43 B11.22%
2017โ‚น90.29 B-36.03%
2016โ‚น141.15 B31.15%
2015โ‚น107.62 B
2013โ‚น223.39 B33.52%
2012โ‚น167.31 B-4.65%
2011โ‚น175.47 B45.53%
2010โ‚น120.57 B